Soltis Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Sell
876
-201
-19% -$87.8K 0.02% 446
2026
Q1
$496K Buy
1,077
+112
+12% +$56.7K 0.03% 335
2025
Q4
$547K Buy
965
+172
+22% +$91.6K 0.04% 309
2025
Q3
$355K Sell
793
-22
-3% -$10.6K 0.02% 348
2025
Q2
$443K Buy
815
+174
+27% +$91K 0.03% 267
2025
Q1
$318K Buy
641
+59
+10% +$32.6K 0.03% 292
2024
Q4
$304K Buy
582
+63
+12% +$32.8K 0.03% 286
2024
Q3
$255K Buy
519
+58
+13% +$27K 0.02% 302
2024
Q2
$205K Buy
+461
New +$184K 0.02% 312

Other funds holding ISRG

Soltis Investment Advisors's ISRG Position: Q2 2026 in Review

Soltis Investment Advisors reduced its Intuitive Surgical (ISRG) stake by 19% in Q2 2026, selling an estimated $87.8K and leaving 876 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #446.

Soltis Investment Advisors first reported a position in ISRG in Q2 2024 and has held it in 9 quarters since. The position peaked at $547K in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Soltis Investment Advisors held 876 shares of Intuitive Surgical worth $348K as of Q2 2026.
  • Soltis Investment Advisors sold 201 Intuitive Surgical shares in Q2 2026, an estimated $87.8K.
  • Intuitive Surgical made up 0.02% of Soltis Investment Advisors's portfolio in Q2 2026, its #446 holding.
  • Soltis Investment Advisors first reported a position in Intuitive Surgical in Q2 2024 and has held it in 9 quarters since.
  • Soltis Investment Advisors's Intuitive Surgical position peaked at $547K in Q4 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.